Syndax Pharmaceuticals (SNDX) Return on Assets (2016 - 2026)

Syndax Pharmaceuticals' Return on Assets history runs 11 years deep, the most recent figure standing at 0.0% for Q1 2026.

• On a quarterly basis, Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026; TTM through Mar 2026 was 0.0%, a 0.0% change from a year earlier, with the FY2025 full-year figure at 0.0%, changed 0.0% from the prior year.
• Return on Assets rose to 0.0% in Q1 2026 per SNDX's latest filing, from 0.01% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q1 2022 and bottomed at 0.01% in Q3 2024.
• The 5-year median for Return on Assets is 0.0% (2023), against an average of 0.0%.
• Biggest YoY gain for Return on Assets was 0 bps in 2022; the steepest drop was 0 bps in 2022.
• Year by year, Return on Assets stood at 0.0% in 2022, then decreased by 18 bps to 0.0% in 2023, then slumped by 44 bps to 0.01% in 2024, then rose by 11 bps to 0.01% in 2025, then advanced by 8 bps to 0.0% in 2026.
• Per Business Quant, the three latest SNDX Return on Assets figures stand at 0.0% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025).